Insider Transactions in Q2 2019 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2019
|
Ann Powell EVP, Chief Human Resources |
SELL
Other acquisition or disposition
|
Direct |
41,545
-56.62%
|
-
|
|
May 16
2019
|
Theodore R. Samuels Ii Director |
BUY
Open market or private purchase
|
Direct |
5,000
+15.63%
|
$235,000
$47.29 P/Share
|
|
May 16
2019
|
Karen Murphy Santiago SVP & Controller |
SELL
Open market or private sale
|
Direct |
3,065
-49.99%
|
$144,055
$47.56 P/Share
|
|
May 05
2019
|
Giovanni Caforio Executive Chair of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
2,774
-0.75%
|
$133,152
$48.62 P/Share
|
|
May 05
2019
|
Giovanni Caforio Executive Chair of the Board |
SELL
Other acquisition or disposition
|
Direct |
2,399
-0.64%
|
-
|
|
May 05
2019
|
Giovanni Caforio Executive Chair of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
8,040
+2.11%
|
-
|
|
Apr 03
2019
|
Thomas J. Lynch Jr. EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,171
-12.65%
|
$283,866
$46.88 P/Share
|
|
Apr 03
2019
|
Thomas J. Lynch Jr. EVP & Chief Scientific Officer |
SELL
Other acquisition or disposition
|
Direct |
773
-2.99%
|
-
|
|
Apr 03
2019
|
Thomas J. Lynch Jr. EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,594
+18.95%
|
-
|